Focused Wealth Management’s Acorda Therapeutics ACOR Stock Holding History

Focused Wealth Management’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8	Closed	-$1K	–	937
2020 Q3	$1K	Hold	8	–	–	﹤0.01%	763
2020 Q2	$1K	Hold	8	–	–	﹤0.01%	744
2020 Q1	$1K	Hold	8	–	–	﹤0.01%	692
2019 Q4	$2K	Hold	8	–	–	﹤0.01%	657
2019 Q3	$3K	Hold	8	–	–	﹤0.01%	623
2019 Q2	$8K	Hold	8	–	–	﹤0.01%	546
2019 Q1	$13K	Hold	8	–	–	﹤0.01%	435
2018 Q4	$16K	Hold	8	–	–	0.01%	406
2018 Q3	$20K	Hold	8	–	–	0.01%	367
2018 Q2	$29K	Hold	8	–	–	0.01%	326
2018 Q1	$24K	Hold	8	–	–	0.01%	369
2017 Q4	$21K	Hold	8	–	–	0.01%	377
2017 Q3	$24K	Buy	+8	New	+$21.1K	0.01%	328
2016 Q1	–	Sell	-1	Closed	-$4K	–	729
2015 Q4	$4K	Hold	1	–	–	﹤0.01%	538
2015 Q3	$3K	Hold	1	–	–	﹤0.01%	561
2015 Q2	$3K	Hold	1	–	–	﹤0.01%	561
2015 Q1	$3K	Hold	1	–	–	﹤0.01%	582
2014 Q4	$4K	Hold	1	–	–	﹤0.01%	539
2014 Q3	$3K	Hold	1	–	–	﹤0.01%	571
2014 Q2	$3K	Hold	1	–	–	﹤0.01%	570
2014 Q1	$4K	Hold	1	–	–	﹤0.01%	518
2013 Q4	$3K	Hold	1	–	–	﹤0.01%	534
2013 Q3	$3K	Buy	+1	New	+$4.31K	﹤0.01%	502

Other funds holding ACOR

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Focused Wealth Management's ACOR Position: Q4 2020 in Review

Focused Wealth Management sold out of Acorda Therapeutics (ACOR) in Q4 2020, closing a stake of 8 shares — an estimated $1K sold.

Focused Wealth Management first reported a position in ACOR in Q3 2013 and held it in 23 quarters. The position peaked at $29K in Q2 2018. 47 funds tracked by Wall St. Rank hold ACOR as of Q4 2020.

Focused Wealth Management reported no remaining Acorda Therapeutics position as of Q4 2020 after selling out during the quarter.
Focused Wealth Management sold 8 Acorda Therapeutics shares in Q4 2020, an estimated $1K.
Focused Wealth Management first reported a position in Acorda Therapeutics in Q3 2013 and held it in 23 quarters.
Focused Wealth Management's Acorda Therapeutics position peaked at $29K in Q2 2018.
47 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2020.

Based on Focused Wealth Management's 13F filing for Q4 2020, filed 3 Feb 2021.